Tag: should

  • Pfizer Ceo Predicts ‘constant Waves’ Of Covid-19, Blames Complacency

    By Amruta Khandekar and Leroy Leo – Plunging valuations have made biotech businesses tempting acquisition targets for cash-wealthy Large Pharma and a flurry of bargains is just… Pfizer’s 2021 income of $81.three billion was practically double the mark from the previous year, due to COVID-19 vaccine sales. With the addition of its COVID-19 antiviral pill […]